The global cervical cancer treatment market is experiencing consistent growth due to the rising prevalence of cervical cancer, increasing HPV infections, and expanding access to advanced oncology therapies. The industry is projected to grow from US$ 10.26 billion in 2024 to US$ 14.91 billion by 2031, registering a CAGR of 5.7% during 2025–2031. Cervical cancer remains one of the most...